<DOC>
	<DOCNO>NCT01769664</DOCNO>
	<brief_summary>The objective study compare relative efficacy safety test formulation Clindamycin 1 % /Benzoyl Peroxide 5 % Topical Gel ( Taro Pharmaceuticals Inc. ) market formulation Duac速 Topical Gel ( Clindamycin 1 % /Benzoyl Peroxide 5 % ) ( Stiefel ) treatment inflamed lesion acne vulgaris . Both test reference formulation also compare placebo formulation test superiority .</brief_summary>
	<brief_title>A Study Comparing Clindamycin 1 % /Benzoyl Peroxide 5 % Topical Gel Duac速 Topical Gel Treatment Acne Vulgaris</brief_title>
	<detailed_description />
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Clindamycin</mesh_term>
	<mesh_term>Clindamycin palmitate</mesh_term>
	<mesh_term>Clindamycin phosphate</mesh_term>
	<mesh_term>Benzoyl Peroxide</mesh_term>
	<criteria>Male nonpregnant , nonlactating female , 12 40 year age clinical diagnosis acne vulgaris . Signed informed consent form . For minor , parent legal guardian sign consent form patient sign assent participate form . If female childbearing potential , prepare abstain sexual intercourse use reliable method contraception study . Patients hormonal contraceptive must three month prior baseline visit continue throughout duration study . Have facial acne 20 facial inflammatory lesion 25 noninflammatory lesion 2 less nodulocystic lesion Investigator Global Assessment score 2 , 3 4 . Willing comply study requirement restriction include refrain use topical acne medication antibiotics treatment period . Patient 2 facial nodular lesion . Patient active cystic acne . Patient acne conglobata . Patients excessive facial hair would interfere diagnosis assessment acne . Patients tatoos excessive facial scarring may interfere evaluation patient 's acne . Patients active facial sunburn , peel due sunburn patient expose excessive sunlight study . Any skin condition acne vulgaris would interfere evaluation patient 's acne . Females pregnant , lactate likely become pregnant study . Patients history active colitis irritable bowel syndrome . History allergy hypersensitivity Clindamycin , Lincomycin benzoyl peroxide history drug hypersensitivity intolerance would compromise patient 's safety study . Significant history current evidence chronic infectious disease , system disorder , organ disorder medical condition would place patient undue risk participation . Use face within 1 month prior screening/baseline study follow : cryodestruction chemodestruction , dermabrasion , photodynamic therapy , acne surgery , intralesional steroid , xray therapy . Use follow within 1 month prior screening/baseline : spironolactone , systemic steroid , systemic antibiotic , systemic treatment acne vulgaris ( oral retinoids require 6 month washout ) , systemic antiinflammatory agent . Use oral isotretinoin ( Accutane速 ) oral retinoids within 6 month , therapeutic vitamin A supplement great 10,000 units/day . Use within 2 week prior screening/baseline follow : topical steroid , topical retinoids , topical acne treatment include overthecounter preparation , topical antiinflammatory agent , medicate cleanser , topical antibiotic . Receipt drug part research study within 30 day . Female patient take hormonal contraceptive oral estrogen le 3 month plan change dosage regimen course study . Previous participation study . Employees investigator research center immediate family member .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Acne vulgaris</keyword>
	<keyword>Clindamycin 1 % /Benzoyl Peroxide 5 % Topical Gel</keyword>
	<keyword>Duac速 Topical Gel</keyword>
</DOC>